The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection.

Hepatic resection Hepatocellular carcinoma Prognosis Rapid turnover protein Sarcopenia

Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 05 02 2021
accepted: 03 07 2021
pubmed: 8 9 2021
medline: 18 11 2021
entrez: 7 9 2021
Statut: ppublish

Résumé

Nutritional status assessment is essential in cancer patients because a poor nutritional status has been associated with poor outcomes; however, the impact of rapid turnover proteins (RTPs), such as prealbumin, transferrin, and retinol-binding protein, on the outcomes of hepatocellular carcinoma (HCC) has not been well-investigated. We therefore examined the prognostic significance of RTPs in patients with HCC after curative resection. This study included 150 patients who underwent elective hepatic resection for HCC between January 2011 and December 2018. The prealbumin, transferrin, and retinol-binding protein levels were classified into two groups (high vs. low); the RTP score (0-3) was calculated as the sum of each RTP measurement (high = 0; low = 1). We retrospectively investigated the relationship between the RTP score and disease-free and overall survival. Multivariate analysis showed that a high RTP score (P = 0.022), presence of sarcopenia (P = 0.001), and stage III or higher (P = 0.005) were independent predictors of disease-free survival, while a high RTP score (P < 0.001), presence of sarcopenia (P = 0.017), and stage III or higher (P = 0.012) were independent predictors of overall survival. In patients with high RTP scores, positive hepatitis B and C viral infection, high indocyanine green (ICG) at 15 min (ICG The preoperative RTP score may be a prognostic factor in patients with hepatocellular carcinoma after hepatic resection, suggesting an important role of RTP in the assessment of nutritional status in cancer patients.

Sections du résumé

BACKGROUND BACKGROUND
Nutritional status assessment is essential in cancer patients because a poor nutritional status has been associated with poor outcomes; however, the impact of rapid turnover proteins (RTPs), such as prealbumin, transferrin, and retinol-binding protein, on the outcomes of hepatocellular carcinoma (HCC) has not been well-investigated. We therefore examined the prognostic significance of RTPs in patients with HCC after curative resection.
METHODS METHODS
This study included 150 patients who underwent elective hepatic resection for HCC between January 2011 and December 2018. The prealbumin, transferrin, and retinol-binding protein levels were classified into two groups (high vs. low); the RTP score (0-3) was calculated as the sum of each RTP measurement (high = 0; low = 1). We retrospectively investigated the relationship between the RTP score and disease-free and overall survival.
RESULTS RESULTS
Multivariate analysis showed that a high RTP score (P = 0.022), presence of sarcopenia (P = 0.001), and stage III or higher (P = 0.005) were independent predictors of disease-free survival, while a high RTP score (P < 0.001), presence of sarcopenia (P = 0.017), and stage III or higher (P = 0.012) were independent predictors of overall survival. In patients with high RTP scores, positive hepatitis B and C viral infection, high indocyanine green (ICG) at 15 min (ICG
CONCLUSION CONCLUSIONS
The preoperative RTP score may be a prognostic factor in patients with hepatocellular carcinoma after hepatic resection, suggesting an important role of RTP in the assessment of nutritional status in cancer patients.

Identifiants

pubmed: 34490525
doi: 10.1245/s10434-021-10704-9
pii: 10.1245/s10434-021-10704-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8130-8139

Subventions

Organisme : Uehara Memorial Foundation
ID : research grant
Organisme : Japan Society for the Promotion of Science
ID : JP21K08718
Organisme : Japan Society for the Promotion of Science
ID : JP21K08805

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. Society of Surgical Oncology.

Références

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
doi: 10.3322/caac.21262
Yang HJ, Guo Z, Yang YT, et al. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis. World J Gastroenterol. 2016;22:5088–95.
doi: 10.3748/wjg.v22.i21.5088
Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol. 2012;29:2005–9.
doi: 10.1007/s12032-011-0019-5
Yang J, Bao Y, Chen W, Duan Y, Sun D. Nomogram based on systemic immune inflammation index and prognostic nutrition index predicts recurrence of hepatocellular carcinoma after surgery. Front Oncol. 2020;10:551668.
doi: 10.3389/fonc.2020.551668
Shen Y, Wang H, Li W, Chen J. Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA. J Clin Lab Anal. 2019;33:e22999.
pubmed: 31418936 pmcid: 6868405
Yang YT, Jiang JH, Yang HJ, Wu ZJ, Xiao ZM, Xiang BD. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Sci Rep. 2018;8:2535.
doi: 10.1038/s41598-018-20199-2
He C, Zhang Y, Cai Z, Lin X. The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy. Cancer Manag Res. 2019;11:1391–400.
doi: 10.2147/CMAR.S190545
Pan J, Chen S, Tian G, Jiang T. Preoperative albumin-bilirubin grade with prognostic nutritional index predicts the outcome of patients with early-stage hepatocellular carcinoma after percutaneous radiofrequency ablation. Front Med (Lausanne). 2020;7:584871.
doi: 10.3389/fmed.2020.584871
Watanabe T, Shibata M, Nishiyama H, et al. Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer. Oncol Lett. 2014;7:373–7.
doi: 10.3892/ol.2013.1735
Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589–94.
doi: 10.1016/S0002-9610(99)80227-X
Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12:351–5.
doi: 10.1007/s00534-005-0999-7
Ueno S, Tanabe G, Nuruki K, et al. Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res. 2002;24:395–403.
doi: 10.1016/S1386-6346(02)00144-4
Nagai S, Mangus RS, Kubal CA, et al. Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival. Clin Transplant. 2015;29:1156–63.
doi: 10.1111/ctr.12644
Haruki K, Shiba H, Shirai Y, et al. The C-reactive protein to albumin ratio predicts long-term outcomes in patients with pancreatic cancer after pancreatic resection. World J Surg. 2016;40:2254–60.
doi: 10.1007/s00268-016-3491-4
Masuda T, Shirabe K, Ikegami T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl. 2014;20:401–7.
doi: 10.1002/lt.23811
Toyoda H, Lai PB, O’Beirne J, et al. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer. 2016;114:744–50.
doi: 10.1038/bjc.2016.33
Inoue Y, Nezu R, Matsuda H, Takagi Y, Okada A. Rapid turnover proteins as a prognostic indicator in cancer patients. Surg Today. 1995;25:498–506.
doi: 10.1007/BF00311305
Cavarocchi NC, Au FC, Dalal FR, Friel K, Mildenberg B. Rapid turnover proteins as nutritional indicators. World J Surg. 1986;10:468–73.
doi: 10.1007/BF01655311
Hu X, Huang W, Wang F, et al. Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: a case-control study. Medicine (Baltimore). 2020;99:e21254.
doi: 10.1097/MD.0000000000021254
Norden AGW, Burling KA, Zeni L, Unwin RJ. A new estimate of the glomerular sieving coefficient for retinol-binding protein 4 suggests it is not freely filtered. Kidney Int Rep. 2019;4:1017–8.
doi: 10.1016/j.ekir.2019.04.017
Dong ZR, Zou J, Sun D, et al. Preoperative albumin-bilirubin score for postoperative solitary hepatocellular carcinoma within the milan criteria and child-pugh a cirrhosis. J Cancer. 2017;8:3862–7.
doi: 10.7150/jca.21313
Liao YY, Teng CL, Peng NF, et al. Serum prealbumin is negatively associated with survival in hepatocellular carcinoma patients after hepatic resection. J Cancer. 2019;10:3006–11.
doi: 10.7150/jca.30903
Cavallin F, Scarpa M, Cagol M, Alfieri R, Castoro C. Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg. 2013;37:2005.
doi: 10.1007/s00268-013-1937-5
Yuan S, Carter P, Vithayathil M, et al. Iron status and cancer risk in UK biobank: a two-sample mendelian randomization study. Nutrients. 2020;12:526.
doi: 10.3390/nu12020526
Shimura T, Shibata M, Inoue T, et al. Prognostic impact of serum transthyretin in patients with non-small cell lung cancer. Mol Clin Oncol. 2019;10:597–604.
pubmed: 31031974 pmcid: 6482388
Harimoto N, Yoshizumi T, Shimokawa M, et al. Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma. Hepatol Res. 2016;46:1247–55.
doi: 10.1111/hepr.12674
Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63:131–40.
doi: 10.1016/j.jhep.2015.02.031
McCowen KC, Bistrian BR. Immunonutrition: problematic or problem solving? Am J Clin Nutr. 2003;77:764–70.
doi: 10.1093/ajcn/77.4.764
Giger U, Buchler M, Farhadi J, et al. Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol. 2007;14:2798–806.
doi: 10.1245/s10434-007-9407-7
Mocellin MC, Fernandes R, Chagas TR, Trindade E. A meta-analysis of n-3 polyunsaturated fatty acids effects on circulating acute-phase protein and cytokines in gastric cancer. Clin Nutr. 2018;37:840–50.
doi: 10.1016/j.clnu.2017.05.008

Auteurs

Mitsuru Yanagaki (M)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Koichiro Haruki (K)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan. haruki@jikei.ac.jp.

Jungo Yasuda (J)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Kenei Furukawa (K)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Shinji Onda (S)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Masashi Tsunematsu (M)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Yoshihiro Shirai (Y)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Takeshi Gocho (T)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Tomohiko Taniai (T)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Ryoga Hamura (R)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Toru Ikegami (T)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH